Moderna to acquire OriCiro Genomics
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA ...
Read moreModerna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA ...
Read moreKarkinos Healthcare Private Limited (KHPL) and the Indian Institute of Technology-Guwahati (IIT-G) signed a memorandum of understanding (MoU) on Sept ...
Read moreModerna said it was suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing ...
Read moreRansomware attacks against healthcare companies are increasing, leaving hospitals and other care facilities’ data vulnerable to cyber-hackers’ demands According to ...
Read moreCordlife Group Limited (Cordlife), a Singapore Exchange mainboard listed consumer healthcare company, and AMILI Pte Ltd (AMILI), recently announced a ...
Read moreAccording to the Food and Drug Administration (FDA), three doses of the Pfizer-BioNTech coronavirus vaccine appeared to be effective in ...
Read moreON MARCH 31, the World Health Organisation (WHO) released the meeting report of “WHO Expert Meeting on Evaluation of Traditional ...
Read moreMODERNA’S Covid-19 vaccine works in babies, toddlers and preschoolers, the company announced on March 23, 2022, a development that could ...
Read morePERIPHERAL Artery Disease, or PAD, is a leading cause of amputations in the US. But the disease can be silent, ...
Read moreA joint study by the Singapore General Hospital (SGH) and Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise ...
Read moreRevon Media Sdn Bhd
A-5-1, Block A, Parklane Commercial Hub,
Jalan SS 7/26, SS7, 47301 Petaling Jaya,
Selangor Darul Ehsan, Malaysia.
Tel: +603 7886 6091
Fax: +6 03 3358 0303
Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use